ACE2 and COVID-19: Reviewing data from clinical studies analyzing the relationship between ACEI/ARB use and outcome of COVID-19 or ACE2 expression in humans led to the conclusion that heterogeneity and quality of these clinical studies preclude writing a reliable and conclusive review on this topic; this view is supported by some recent reports (Grover and Oberoi, 2020; Liu et al., 2020).